Skip to main content Accessibility help
×
Home

Second primary lung cancer following laryngeal cancer: retrospective study of incidence and multivariate analysis of risk factors in 209 patients

  • M Adams (a1), G Gray (a1), A Kelly (a1), F Toner (a1) and R Ullah (a1)...

Abstract

Objective

To analyse the incidence of second primary lung cancer following treatment for laryngeal cancer and to identify risk factors for its development.

Method

Retrospective case series.

Results

The five-year actuarial incidence of second primary lung cancer was 8 per cent (1.6 per cent per year). This was associated with a very poor median survival of seven months following diagnosis. Supraglottic tumours were associated with an increased risk of second primary lung cancer compared to glottic tumours in both univariate (hazard ratio = 4.32, p = 0.005) and multivariate analyses (hazard ratio = 4.14, p = 0.03).

Conclusion

Second primary lung cancer occurs at a rate of 1.6 per cent per year following a diagnosis of laryngeal cancer, and this is associated in a statistically significant manner with supraglottic primary tumour. The recent National Lung Cancer Screening Trial suggests a survival advantage of 20 per cent at five years with annual screening using low-dose computed tomography scanning of the chest in a comparable cohort to ours. These findings have the potential to inform post-treatment surveillance protocols in the future.

Copyright

Corresponding author

Author for correspondence: Mr Mark Adams, Department of Otolaryngology/Head and Neck Surgery, Royal Victoria Hospital, Belfast BT12 6BA, Northern Ireland, UK E-mail: Jadams08@qub.ac.uk

Footnotes

Hide All

Mr M Adams takes responsibility for the integrity of the content of the paper

Footnotes

References

Hide All
1Sjögren, EV, Snijder, S, van Beekum, J, Baatenburg de Jong, RJB. Second malignant neoplasia in early (Tis-T2) glottic carcinoma. Head Neck 2006;28:501–7
2Makeieff, M, Mercante, G, Jouzdani, E, Garrel, R, Crampette, L, Guerrier, B. Supraglottic hemipharyngolaryngectomy for the treatment of T1 and T2 carcinomas of the laryngeal margin and pyriform sinus. Head Neck 2004;26:701–5
3Colosanto, JM, Haffty, BG, Wilson, LD. Evaluation of local recurrence and second malignancy in patients with T1 and T2 squamous cell carcinoma of the larynx. Cancer J 2004;10:61–6
4Brandsorp-Boesen, J, Falk, RS, Evensen, JF, Boysen, M, Brøndbo, K. Risk of recurrence in laryngeal cancer. PLoS One 2016;11:e01644068
5Paleri, V, Roland, N. Introduction to the United Kingdom National Multidisciplinary Guidelines for Head and Neck Cancer. J Laryngol Otol 2016;130(suppl 2):S34
6Baxi, SS, Pinheiro, LC, Patil, SM, Pfister, DG, Oeffinger, KC, Elkin, EB. Causes of death in long-term survivors of head and neck cancer. Cancer 2014;120:1507–13
7Milano, MT, Peterson, CR 3rd, Zhang, H, Singh, DP, Chen, Y. Second primary lung cancer after head and neck squamous cell cancer: population-based study of risk factors. Head Neck 2012;34:1782–8
8Chuang, SC, Scelo, G, Tonita, JM, Tamao, S, Jonasson, JG, Kliewer, EV et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 2008;123:2390–6
9Pagedar, NA, Jayawardena, A, Charlton, ME, Hoffman, HT. Second primary lung cancer after head and neck cancer: implications for screening computed tomography. Ann Otol Rhinol Laryngol 2015;124:765–9
10Jayaprakash, V, Cheng, C, Reid, M, Dexter, EU, Nwogu, CE, Hicks, W et al. Previous head and neck cancers portend poor prognoses in lung cancer patients. Ann Thorac Surg 2011;92:1056–61
11Dhooge, IJ, De Vos, M, Van Cauwenberge, PB. Multiple primary malignant tumours in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 1998;108:250–6
12Koppe, MJ, Zoetmulder, FA, van Zandewijk, N, Hart, AA, Rutgers, EJ. The prognostic significance of a previous malignancy in operable non-small cell lung cancer. Lung Cancer 2001;32:4753
13Cetinkaya, E, Veyseller, B, Yildirim, YS, Aksoy, F, Ozgül, MA, Gençoğlu, A. Value of autofluorescence bronchoscopy in patients with laryngeal cancer. J Laryngol Otol 2011;125:181–7
14Lee, P, de Bree, R, Brokx, HA, Leemans, CR, Postmus, PE, Sutedja, TG. Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: is there a role for autofluorescence bronchoscopy? Lung Cancer 2008;62:309–15
15Shah, SI, Applebaum, EL. Lung cancer after head and neck cancer: role of chest radiography. Laryngoscope 2000;110:2033–6
16Shimizu, N, Ando, A, Teramoto, S, Moritani, Y, Nishii, K. Outcome of patients with lung cancer detected via mass screening as compared to those presenting with symptoms. J Surg Oncol 1992;50:711
17Engelen, AM, Stalpers, LJ, Manni, JJ, Ruijs, JH, van Daal, WA. Yearly chest radiography in the early detection of lung cancer following laryngeal cancer. Eur Arch Otolaryngol 1992;249:364–9
18Henschke, CI, McCauley, DI, Yankelevitz, DF, Naidich, DP, McGuinness, G, Miettinen, OS et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99105
19National Lung Screening Trial Research Team, Aberle, DR, Adams, AM, Berg, CD, Black, WC, Clapp, JD et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395409
20National Comprehensive Cancer Network. Lung Cancer Screening. In: www.nccn.org/patients/guidelines/lung_screening [27 September 2019]
21Bishop, JA, Ogawa, T, Chang, X, Illei, PB, Gabrielson, E, Pai, SI et al. HPV analysis in distinguishing second primary tumours from lung metastases in patients with head and neck squamous cell carcinoma. Am J Surg Pathol 2012;36:142–8
22Geurts, TW, Balm, AJ, van Velthuysen, ML, van Tinteren, H, Burgers, JA, van Zandwijk, N. Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer. Head Neck 2009;31:220–6
23Chen, MC, Huang, WC, Chan, CH, Chen, PT, Lee, KT. Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer. Oral Oncol 2010;46:249–54
24Dequanter, D, Shahla, M, Lardinois, I, Gilbert, O, Hanquet, O, Tragas, G et al. Second primary lung malignancy in head and neck cancer patients. Eur Ann Otorhinolaryngol Head Neck Dis 2011;128:1113
25Silvestri, F, Bussani, R, Cosatti, C, Bosatra, A. High relative risk of a second pulmonary cancer in patients affected by laryngeal cancer: differences by specific site of occurrence and lung cancer histotype. Laryngoscope 1994;104:222–5
26Lin, K, Patel, SG, Chu, PY, Matsuo, JM, Singh, B, Wong, RJ et al. Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 2005;27:1042–8
27Chu, PY, Chang, SY, Huang, JL, Tai, SK. Different patterns of second primary malignancy in patients with squamous cell carcinoma of the larynx and hypopharynx. Am J Otolaryngol 2010;31:168–74
28Gao, X, Fisher, SG, Mohideen, N, Emami, B. Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003;56:427–35
29Jones, AS, Morar, P, Phillips, DE, Field, JK, Husbband, D, Helliwell, TR. Second primary tumours in patients with head and neck squamous cell carcinoma. Cancer 1995;75:1343–53
30van Smeden, M, de Groot, JA, Moons, KG, Collins, GS, Altman, DG, Eijkemans, MJ et al. No rationale for 1 variable per 10 events criterion for binary logistic regression analysis. BMC Med Res Methodol 2016;16:163

Keywords

Second primary lung cancer following laryngeal cancer: retrospective study of incidence and multivariate analysis of risk factors in 209 patients

  • M Adams (a1), G Gray (a1), A Kelly (a1), F Toner (a1) and R Ullah (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed